Evidence map›Paper›PMID 27550649›Full record

ArticleScientific reports2016

Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs.

Ying Qu, Bo Zhou, Wei Yang, Bingchen Han, Yi Yu-Rice, Bowen Gao, Jeffery Johnson, Clive N Svendsen, Michael R Freeman, Armando E Giuliano and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential.Journal of experimental & clinical cancer research : CR · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Stage-Specific Role ofInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Protein biomarkers of neural system.Journal of otology · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ying QuDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Bo ZhouDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Wei YangDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Bingchen HanDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Yi Yu-RiceDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Bowen GaoDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Jeffery JohnsonDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Clive N SvendsenBoard of Governors-Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Michael R FreemanDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Armando E GiulianoDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.
Dhruv SareenBoard of Governors-Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Xiaojiang CuiDepartment of Surgery, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, 90048, USA.

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
The Role of FOXCI in Basal-like Breast CancerR01CA151610 · NCI · SAINT JOHN'S CANCER INSTITUTE · PI CUI, XIAOJIANG · 2011 to 2022
$3.8M
Tumor Targeted Corroles for Detection and InterventionR01CA140995 · NCI · CEDARS-SINAI MEDICAL CENTER · PI MEDINA-KAUWE, LALI K · 2010 to 2021
$3.7M
Protein-DNA Drug Carriers for Tumor TargetingR01CA129822 · NCI · CEDARS-SINAI MEDICAL CENTER · PI MEDINA-KAUWE, LALI K · 2009 to 2020
$3.0M
NCI NIH HHS R01 CA129822NCI NIH HHS R01 CA140995NCI NIH HHS R01 CA151610NIDDK NIH HHS P30 DK063491
6 · The paper itself

Abstract

Surface ectoderm (SE) cells give rise to structures including the epidermis and ectodermal associated appendages such as hair, eye, and the mammary gland. In this study, we validate a protocol that utilizes BMP4 and the γ-secretase inhibitor DAPT to induce SE differentiation from human induced pluripotent stem cells (hiPSCs). hiPSC-differentiated SE cells expressed markers suggesting their commitment to the SE lineage. Computational analyses using integrated quantitative transcriptomic and proteomic profiling reveal that TGFβ superfamily signaling pathways are preferentially activated in SE cells compared with hiPSCs. SE differentiation can be enhanced by selectively blocking TGFβ-RI signaling. We also show that SE cells and neural ectoderm cells possess distinct gene expression patterns and signaling networks as indicated by functional Ingenuity Pathway Analysis. Our findings advance current understanding of early human SE cell development and pave the way for modeling of SE-derived tissue development, studying disease pathogenesis, and development of regenerative medicine approaches.

Indexed as

Bone Morphogenetic Protein 4Cell DifferentiationCells, CulturedDiaminesEctodermGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansInduced Pluripotent Stem CellsProteomicsSignal TransductionThiazolesTransforming Growth Factor beta24-diamino-5-phenylthiazoleBone Morphogenetic Protein 4DiaminesThiazolesTransforming Growth Factor beta

Identifiers

PMID27550649
PMCPMC4994084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.